Climb Bio, Inc.

Contributing Author

Recent Articles by Climb Bio, Inc.

Nov-25	Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CLYM GlobeNewswire
Nov-06	Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates CLYM GlobeNewswire
Nov-03	Climb Bio to Present at Upcoming Investor Conferences CLYM GlobeNewswire
Oct-21	Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy CLYM GlobeNewswire
Oct-17	Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 CLYM GlobeNewswire
Oct-01	Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer CLYM GlobeNewswire
Sep-29	Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN CLYM GlobeNewswire
Sep-04	Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025 CLYM GlobeNewswire
Aug-25	UPDATE - Climb Bio to Present at Upcoming September 2025 Investor Conferences CLYM GlobeNewswire
Aug-25	Climb Bio to Present at Upcoming September 2025 Investor Conferences CLYM GlobeNewswire
Aug-12	Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates CLYM GlobeNewswire
Jun-18	Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer CLYM GlobeNewswire
May-19	Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CLYM GlobeNewswire
May-14	Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates CLYM GlobeNewswire